Standpoint Research Lifts Price Target On Endo Pharmaceuticals (ENDP) to $44

October 7, 2010 10:26 AM EDT Send to a Friend

Standpoint Research raised its price target on Endo ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Standpoint Research Lifts Price Target On Endo Pharmaceuticals (ENDP) to $44

Member Login

Free News Feed